A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood
Clinical trial NCT05723874 · COMPLETED
Trial details
- NCT number
- NCT05723874
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-06
- Primary completion
- 2023-05-26
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.